STOCK TITAN

Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Elanco Animal Health to attend Morgan Stanley conference
Positive
  • Participation in the Morgan Stanley conference could generate positive investor interest
Negative
  • None.

GREENFIELD, Ind.--(BUSINESS WIRE)-- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 and Tuesday, September 12, 2023. Jeff Simmons, president and CEO, will participate in a fireside chat on Monday at 4:15 p.m. ET.

A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.

ABOUT ELANCO

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com

Investor Contact:

Katy Grissom

(317) 273-9248

kathryn.grissom@elancoah.com

Media Contact:

Colleen Parr Dekker

(317) 989-7011

colleen_parr_dekker@elancoah.com

Source: Elanco Animal Health Incorporated

Elanco Animal Health Incorporated

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Stock Data

6.27B
494.33M
0.66%
99.33%
2.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GREENFIELD